The role of il10 and il17 gene polymorphisms in treatment response in children and adolescents with severe asthma
| dc.creator | Marianaisadora Ribeiro Vieira | |
| dc.creator | Mônica Versiani Nunes Pinheiro de Queiroz | |
| dc.creator | Maria Borges Rabelo de Santana | |
| dc.creator | Hatilla Dos Santos Silva | |
| dc.creator | Almirane Oliveira | |
| dc.creator | Camila Alexandrina Viana Figueiredo | |
| dc.creator | Eduardo Martín Tarazona Santos | |
| dc.creator | Ryan Dos Santos Costa | |
| dc.creator | Maria de Lima Belizário Facury Lasmar | |
| dc.date.accessioned | 2025-02-04T20:17:39Z | |
| dc.date.accessioned | 2025-09-09T00:03:58Z | |
| dc.date.available | 2025-02-04T20:17:39Z | |
| dc.date.issued | 2023 | |
| dc.format.mimetype | ||
| dc.identifier.doi | 10.36416/1806-3756/e20230092 | |
| dc.identifier.issn | 18063756 | |
| dc.identifier.uri | https://hdl.handle.net/1843/79658 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Jornal Brasileiro de Pneumologia | |
| dc.rights | Acesso Aberto | |
| dc.subject | Polymorphism, Genetic | |
| dc.subject | Interleukin-10 | |
| dc.subject | Interleukin-17 | |
| dc.subject | Asthma | |
| dc.subject.other | Polymorphism, Genetic | |
| dc.subject.other | Interleukin-10 | |
| dc.subject.other | Interleukin-17 | |
| dc.subject.other | Asthma | |
| dc.title | The role of il10 and il17 gene polymorphisms in treatment response in children and adolescents with severe asthma | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 7 | |
| local.citation.issue | 6 | |
| local.citation.spage | 1 | |
| local.citation.volume | 49 | |
| local.description.resumo | Objective: To determine whether polymorphisms of the IL10 and IL17 genes are associated with severe asthma control and bronchodilator reversibility in children and adolescents with severe asthma. Methods: This was a cross-sectional study, nested within a prospective cohort study of patients with severe asthma. Two outcomes were evaluated: asthma control and bronchodilator reversibility. We extracted DNA from peripheral blood and genotyped three single nucleotide polymorphisms: rs3819024and rs2275913 in the IL17A gene; and rs3024498 in the IL10 gene. For the association analyses, we performed logistic regression in three genetic models (allelic, additive, and dominant). Results: The rs3024498 C allele in the IL10 gene was associated with failure to achieve asthma control despite regular treatment (p = 0.02). However, the G allele of the IL17A rs3819024 polymorphism was associated with failure to respond to stimulation with a β2 agonist. The rs2275913 polymorphism of the IL17A gene showed no relationship with asthma control or bronchodilator reversibility. Conclusions: In pediatric patients with severe asthma, the IL10 polymorphism appears to be associated with failure to achieve clinical control, whereas the IL17A polymorphism appears to be associated with a worse bronchodilator response. Knowledge of the involvement of these polymorphisms opens future directions for pharmacogenetic studies and for the implementation of individualized therapeutic management of severe asthma in pediatric patients. | |
| local.publisher.country | Brasil | |
| local.publisher.department | MED - DEPARTAMENTO DE PEDIATRIA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://doi.org/10.36416/1806-3756/e20230092 |